Hatteras Venture Partners
Status
ACTIVE
Global HQ
District of Columbia, United States
Countries of investment
- USA
Investment stages
- Seed
Industries
- Health Tech
- Biotechnology
- AI
- Data science
About
Hatteras Venture Partners is a preclinical stage startup that specializes in developing a versatile epigenetic editing platform aimed at creating innovative solutions for various medical applications, particularly in the field of human medicine.
Hatteras Venture Partners is a preclinical stage startup that specializes in developing a versatile epigenetic editing platform aimed at creating innovative solutions for various medical applications, particularly in the field of human medicine.
Investment Thesis
Hatteras Venture Partners’ investment thesis is centered on identifying and investing in early stage companies with transformative technologies in healthcare and life sciences. The firm targets startups with strong scientific foundations, promising clinical and commercial potential, and capable management teams.
Manager's Experience
With a robust background in private equity, the fund manager has successfully overseen numerous investments across diverse sectors, including technology, healthcare, and consumer services. Active primarily in North America and Europe, they have executed over 50 deals, demonstrating a strong operator-first approach that prioritizes strategic partnerships. Their portfolio showcases notable exits that reflect a data-driven investment philosophy, focusing on growth-stage companies poised for substantial market impact. By leveraging deep industry insights, the manager effectively identifies emerging trends and thematic opportunities to drive value creation.
Team
Robert Ingram
Myla La
Kim Hodges
Kenneth Lee
John Crumpler
Jeff Terrell
Fred Goldwater
Douglas Reed
Douglas Reed
Clay Thorp